Member Exclusive News

The week in industry: ‘Outcome-based payment’ could help cancer drugs reach patients sooner

This week: The US FDA has approved an sNDA for CINVANTI®, Cell Medica receive US $8.7 million to develop cancer therapies and an integrin research and development collaboration has been announced

Thumb untitled design
Feb 28, 2019
0
0

Please sign in or register for FREE

No comments yet.